Literature DB >> 18703704

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.

K-John J Cheung1, Sohrab P Shah, Christian Steidl, Nathalie Johnson, Thomas Relander, Adele Telenius, Betty Lai, Kevin P Murphy, Wan Lam, Abdulwahab J Al-Tourah, Joseph M Connors, Raymond T Ng, Randy D Gascoyne, Douglas E Horsman.   

Abstract

The secondary genetic events associated with follicular lymphoma (FL) progression are not well defined. We applied genome-wide BAC array comparative genomic hybridization to 106 diagnostic biopsies of FL to characterize regional genomic imbalances. Using an analytical approach that defined regions of copy number change as intersections between visual annotations and a Hidden Markov model-based algorithm, we identified 71 regional alterations that were recurrent in at least 10% of cases. These ranged in size from approximately 200 kb to 44 Mb, affecting chromosomes 1, 5, 6, 7, 8, 10, 12, 17, 18, 19, and 22. We also demonstrated by cluster analysis that 46.2% of the 106 cases could be sub-grouped based on the presence of +1q, +6p/6q-, +7, or +18. Survival analysis showed that 21 of the 71 regions correlated significantly with inferior overall survival (OS). Of these 21 regions, 16 were independent predictors of OS using a multivariate Cox model that included the international prognostic index (IPI) score. Two of these 16 regions (1p36.22-p36.33 and 6q21-q24.3) were also predictors of transformation risk and independent of IPI. These prognostic features may be useful to identify high-risk patients as candidates for risk-adapted therapies.

Entities:  

Mesh:

Year:  2008        PMID: 18703704     DOI: 10.1182/blood-2008-02-140616

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.

Authors:  Derville O'Shea; Ciarán O'Riain; Manu Gupta; Rachel Waters; Youwen Yang; David Wrench; John Gribben; Andreas Rosenwald; German Ott; Lisa M Rimsza; Harald Holte; Jean-Baptiste Cazier; Nathalie A Johnson; Elias Campo; Wing C Chan; Randy D Gascoyne; Bryan D Young; Louis M Staudt; T Andrew Lister; Jude Fitzgibbon
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

Review 2.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

Review 3.  Recent advances in the treatment of follicular lymphoma.

Authors:  Yukio Kobayashi
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

4.  Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.

Authors:  Taku Tsukamoto; Miki Kiyota; Eri Kawata; Nobuhiko Uoshima; Shotaro Tatekawa; Yoshiaki Chinen; Hisao Nagoshi; Shinsuke Mizutani; Yuji Shimura; Mio Yamamoto-Sugitani; Tsutomu Kobayashi; Shigeo Horiike; Satoru Yasukawa; Akio Yanagisawa; Masafumi Taniwaki; Junya Kuroda
Journal:  Int J Hematol       Date:  2016-12-19       Impact factor: 2.490

5.  CREBBP gene mutations are frequently detected in in situ follicular neoplasia.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Irina Bonzheim; Julia Steinhilber; Inga Müller; Andrea Haake; Shan Chi Yu; Mark Raffeld; Falko Fend; Itziar Salaverria; Reiner Siebert; Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

Review 6.  Functional genomics lead to new therapies in follicular lymphoma.

Authors:  Elisa Oricchio; Hans-Guido Wendel
Journal:  Ann N Y Acad Sci       Date:  2013-05-15       Impact factor: 5.691

Review 7.  Unmet needs in the first-line treatment of follicular lymphoma.

Authors:  C Casulo; L Nastoupil; N H Fowler; J W Friedberg; C R Flowers
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

8.  Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.

Authors:  Idoia Martin-Guerrero; Itziar Salaverria; Birgit Burkhardt; Monika Szczepanowski; Michael Baudis; Susanne Bens; Laurence de Leval; Africa Garcia-Orad; Heike Horn; Jasmin Lisfeld; Shoji Pellissery; Wolfram Klapper; Ilske Oschlies; Reiner Siebert
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

Review 9.  Lymphotoxin network pathways shape the tumor microenvironment.

Authors:  Ryan L Bjordahl; Christian Steidl; Randy D Gascoyne; Carl F Ware
Journal:  Curr Opin Immunol       Date:  2013-01-20       Impact factor: 7.486

10.  Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Authors:  Ryan D Morin; Nathalie A Johnson; Tesa M Severson; Andrew J Mungall; Jianghong An; Rodrigo Goya; Jessica E Paul; Merrill Boyle; Bruce W Woolcock; Florian Kuchenbauer; Damian Yap; R Keith Humphries; Obi L Griffith; Sohrab Shah; Henry Zhu; Michelle Kimbara; Pavel Shashkin; Jean F Charlot; Marianna Tcherpakov; Richard Corbett; Angela Tam; Richard Varhol; Duane Smailus; Michelle Moksa; Yongjun Zhao; Allen Delaney; Hong Qian; Inanc Birol; Jacqueline Schein; Richard Moore; Robert Holt; Doug E Horsman; Joseph M Connors; Steven Jones; Samuel Aparicio; Martin Hirst; Randy D Gascoyne; Marco A Marra
Journal:  Nat Genet       Date:  2010-01-17       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.